| Title |
Vaccines and multiple sclerosis: a systematic review
|
|---|---|
| Published in |
Journal of Neurology, September 2016
|
| DOI | 10.1007/s00415-016-8263-4 |
| Pubmed ID | |
| Authors |
Mia Topsøe Mailand, Jette Lautrup Frederiksen |
| Abstract |
Vaccinations are often the most effective tool against some disease known to mankind. This study offers a literature review on the role of vaccines regarding the risk of developing multiple sclerosis (MS) and MS relapse. The method used in this study is a systematic literature review on the database PubMed. The study found no change in risk of developing multiple sclerosis (MS) after vaccination against hepatitis B virus, human papillomavirus, seasonal influenza, measles-mumps-rubella, variola, tetanus, Bacillus Calmette-Guérin (BCG), polio, or diphtheria. No change in risk of relapse was found for influenza. Further research is needed for the potential therapeutic use of the BCG vaccine in patients in risk of developing MS and for the preventive potential of the tetanus and diphtheria vaccine. |
X Demographics
The data shown below were collected from the profiles of 73 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 16% |
| Australia | 5 | 7% |
| France | 3 | 4% |
| United Kingdom | 3 | 4% |
| Italy | 2 | 3% |
| Switzerland | 1 | 1% |
| Poland | 1 | 1% |
| Germany | 1 | 1% |
| Turkey | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 41 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 55 | 75% |
| Scientists | 9 | 12% |
| Practitioners (doctors, other healthcare professionals) | 8 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Unknown | 154 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 14% |
| Student > Bachelor | 22 | 14% |
| Researcher | 17 | 11% |
| Other | 15 | 10% |
| Student > Doctoral Student | 10 | 6% |
| Other | 28 | 18% |
| Unknown | 41 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 31% |
| Neuroscience | 17 | 11% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Agricultural and Biological Sciences | 8 | 5% |
| Nursing and Health Professions | 6 | 4% |
| Other | 20 | 13% |
| Unknown | 48 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#501,010
of 25,843,331 outputs
Outputs from Journal of Neurology
#57
of 5,064 outputs
Outputs of similar age
#9,537
of 346,736 outputs
Outputs of similar age from Journal of Neurology
#1
of 45 outputs
Altmetric has tracked 25,843,331 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,064 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,736 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.